Omnipaque Solution
Product Images NDC 0407-1415

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Omnipaque (NDC 0407-1415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Omnipaque Cork 01)

Chemical structure diagram of the active ingredient in OMNIPAQUE, showing a benzene ring with three iodine atoms and functional groups including amide, hydroxyl, and acetonitrile substituents.*

FDA Label Image

Figure (Omnipaque Cork 02)

OMNIPAQUE 140 mg/mL (iohexol) Injection single-dose sterile aqueous solution in a 50 mL PLUSPak polymer bottle. Label shows manufacturer GE Healthcare Inc., usage cautions including 'Not for Intrathecal Use,' storage instructions, and a red and blue color scheme.*

FDA Label Image

Principal Display Panel (140 mgI/mL Bottle Label)

Label for OMNIPAQUE (iohexol) Injection 180 mg/mL single-dose vial, 20 mL sterile aqueous solution. The label includes usage instructions, storage conditions, distributor information (GE Healthcare Inc.), and ingredient concentrations including organic iodine content. The product is of Norwegian origin and intended for single procedure use, with warnings to protect from light and avoid freezing.*

FDA Label Image

Principal Display Panel (180 mgI/mL Vial Label)

Label for OMNIPAQUE 240 mg/mL (iohexol) injection by GE Healthcare Inc. The label identifies it as a sterile aqueous solution in a single-dose bottle with a 150 mL volume. It includes usage instructions, storage conditions, and active ingredient details. The label also shows the NDC 0407-1412-34 and product origin as Norway.*

FDA Label Image

Principal Display Panel (240 mgI/mL Bottle Label)

OMNIPAQUE 300 mg Iodine/mL injection label from GE Healthcare Inc. The label indicates a 150 mL single-dose bottle containing a sterile aqueous solution of iohexol for injection or oral use. It specifies storage instructions, absence of preservatives, and includes regulatory and manufacturer information, including that the product is of Norwegian origin.*

FDA Label Image

Principal Display Panel (300 mgI/mL Bottle Label)

OMNIPAQUE 350 mg iodine/mL injectable solution label from GE Healthcare Inc. The label indicates it is for intravascular, oral, intraarticular, and body cavity use only. It is a single-dose sterile aqueous solution packaged in a 150 mL polymer bottle. The label includes usage instructions, storage conditions (20°-25°C), and ingredient details confirming 755 mg of iohexol per mL.*

FDA Label Image

Principal Display Panel (350 mgI/mL Bottle Label)

Label for OMNIPAQUE 9 mg iodine/mL oral solution by GE Healthcare Inc. It is a single-dose sterile aqueous solution in a 500 mL bottle. The label includes usage instructions, storage conditions, and a graphic indicating oral administration. It states no preservatives added and no dilution required.*

FDA Label Image

Omnipaque Cork 08

Label for OMNIPAQUE 12 mg iodine/mL oral solution by GE Healthcare Inc. The label indicates a 500 mL single-dose bottle, for oral use only, containing iohexol as the active ingredient. It includes dosage details, storage instructions, and warnings about tamper-evident packaging. The label also lists the product's NDC and states it is made in Norway.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.